| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/IJI.12294 |
| P698 | PubMed publication ID | 27870356 |
| P2093 | author name string | N K Mehra | |
| A K Baranwal | |||
| P2860 | cites work | Non-HLA antibodies targeting vascular receptors enhance alloimmune response and microvasculopathy after heart transplantation. | Q52886517 |
| Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation. | Q52889823 | ||
| Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. | Q53243295 | ||
| Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood. | Q53503526 | ||
| Impact of pretransplant human leukocyte antigen-C and -DP antibodies on kidney graft outcome. | Q54338277 | ||
| Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. | Q54469292 | ||
| The perlecan fragment LG3 is a novel regulator of obliterative remodeling associated with allograft vascular rejection. | Q54550531 | ||
| Can C4d Immunostaining on Endomyocardial Biopsies Be Considered a Prognostic Biomarker in Heart Transplant Recipients? | Q58004270 | ||
| Microdroplet Assay of Human Serum Cytotoxins | Q59059757 | ||
| No Association of Kidney Graft Loss With Human Leukocyte Antigen Antibodies Detected Exclusively by Sensitive Luminex Single-Antigen Testing: A Collaborative Transplant Study Report | Q59305666 | ||
| Pre-Transplant Assessment of Donor-Reactive, HLA-Specific Antibodies in Renal Transplantation: Contraindication vs. Risk | Q59314397 | ||
| A second lineage of mammalian major histocompatibility complex class I genes | Q24561936 | ||
| Role of complement and NK cells in antibody mediated rejection | Q26864255 | ||
| Donor-reactive HLA antibodies in renal allograft recipients: considerations, complications, and conundrums. | Q30376242 | ||
| Immunohistochemistry staining of C4d to diagnose antibody-mediated rejection in cardiac transplantation | Q33326201 | ||
| De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection | Q33551885 | ||
| Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation | Q34124202 | ||
| Association of HLA mismatch with death with a functioning graft after kidney transplantation: a collaborative transplant study report | Q34294557 | ||
| Antiperlecan antibodies are novel accelerators of immune-mediated vascular injury | Q34595998 | ||
| A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients | Q34991120 | ||
| De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients | Q35535173 | ||
| Anti-HLA antibody analysis and crossmatching in heart and lung transplantation | Q35808818 | ||
| Long term outcomes of transplantation using kidneys from expanded criteria donors: prospective, population based cohort study. | Q35907637 | ||
| The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation | Q35975914 | ||
| Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation | Q36131035 | ||
| Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss | Q36216606 | ||
| Extending options for highly sensitized patients to receive a suitable kidney graft | Q36220802 | ||
| A structurally based approach to determine HLA compatibility at the humoral immune level | Q36316220 | ||
| Donor-specific antibodies adversely affect kidney allograft outcomes. | Q36426146 | ||
| Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure. | Q36509321 | ||
| Antibody ligation of human leukocyte antigen class I molecules stimulates migration and proliferation of smooth muscle cells in a focal adhesion kinase-dependent manner | Q36584507 | ||
| Effects of influenza immunization on humoral and cellular alloreactivity in humans | Q36661931 | ||
| A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody | Q36887068 | ||
| Antibody mediated rejection: update 2006. | Q36910384 | ||
| A role for antibodies to human leukocyte antigens, collagen-V, and K-α1-Tubulin in antibody-mediated rejection and cardiac allograft vasculopathy | Q37044200 | ||
| Why can sensitization by an HLA-DR2 mismatch lead to antibodies that react also with HLA-DR1? | Q37300454 | ||
| The emerging issue of MICA antibodies: antibodies to MICA and other antigens of endothelial cells | Q37323152 | ||
| Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody | Q37575872 | ||
| Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection | Q37654098 | ||
| Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols | Q37685188 | ||
| Barriers to successful transplantation of the sensitized patient | Q37742103 | ||
| Non-HLA-antibodies targeting Angiotensin type 1 receptor and antibody mediated rejection | Q38028216 | ||
| Clinical relevance of antibody development in renal transplantation | Q38079301 | ||
| Current role of human leukocyte antigen matching in kidney transplantation | Q38120397 | ||
| Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms. | Q38169496 | ||
| Donor-specific antibodies in allograft recipients: etiology, impact and therapeutic approaches | Q38259069 | ||
| HLA epitopes as viewed by antibodies: what is it all about? | Q38364484 | ||
| Incidence and impact of de novo donor-specific alloantibody in primary renal allografts | Q39472834 | ||
| Pre-transplant serum concentrations of anti-endothelial cell antibody in panel reactive antibody negative renal recipients and its impact on acute rejection | Q39800052 | ||
| Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. | Q39904553 | ||
| "Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males | Q39926228 | ||
| Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 | ||
| The relationship of anti-MICA antibodies and MICA expression with heart allograft rejection. | Q40131011 | ||
| Post-transplant soluble MICA and MICA antibodies predict subsequent heart graft outcome | Q40198908 | ||
| The predictive value of soluble major histocompatibility complex class I chain-related molecule A (MICA) levels on heart allograft rejection | Q40244088 | ||
| Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure | Q40386334 | ||
| Flow cytometry based detection of HLA alloantibody mediated classical complement activation. | Q40597066 | ||
| MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes. | Q41069294 | ||
| Major histocompatibility complex class 1 chain-related antigen a antibodies: sensitizing events and impact on renal graft outcomes | Q42171607 | ||
| A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation | Q42607322 | ||
| A comparison of the survival of shipped and locally transplanted cadaveric renal allografts | Q42662484 | ||
| Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause | Q43580802 | ||
| Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss | Q43817587 | ||
| Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death | Q43829027 | ||
| Deleterious impact of HLA-DRB1 allele mismatch in sensitized recipients of kidney retransplants | Q43846537 | ||
| Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: a cohort study. | Q43866270 | ||
| HLA antibody specification using single-antigen beads--a technical solution for the prozone effect | Q43914521 | ||
| Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report | Q43937861 | ||
| Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. | Q44092564 | ||
| Antibodies to liver sinusoidal endothelial cells modulate immune responses in liver transplantation | Q44323282 | ||
| Clinical relevance of anti-HLA donor-specific antibodies detected by Luminex assay in the development of rejection after renal transplantation | Q44418324 | ||
| Shipping donor kidneys within Eurotransplant: outcomes after renal transplantation in a single-centre cohort study. | Q44814399 | ||
| Different impact of pretransplant anti-HLA antibodies detected by Luminex in highly sensitized renal transplanted patients | Q45122553 | ||
| Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution | Q45185527 | ||
| Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions | Q45342440 | ||
| Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation | Q45627897 | ||
| The impact of human leukocyte antigen mismatching on sensitization rates and subsequent retransplantation after first graft failure in pediatric renal transplant recipients | Q45768702 | ||
| Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation. | Q45929361 | ||
| Risk of fractures after renal transplantation in the United States. | Q45960180 | ||
| Early ultrastructural changes in renal allografts: correlation with antibody-mediated rejection and transplant glomerulopathy. | Q45966400 | ||
| Influence of CIT-induced DGF on kidney transplant outcomes. | Q45991458 | ||
| Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period | Q46050956 | ||
| Kidney transplantation in a recipient with anti-HLA antibody IgM positive | Q46056178 | ||
| Deleterious impact of mismatching for human leukocyte antigen-C in presensitized recipients of kidney transplants | Q46086067 | ||
| Impact of HLA mismatching on incidence of posttransplant non-hodgkin lymphoma after kidney transplantation | Q46126470 | ||
| Complement-binding anti-HLA antibodies and kidney-allograft survival | Q46141053 | ||
| HLA high-resolution typing for sensitized patients: a solution in search of a problem? | Q46153238 | ||
| Association of mismatches for HLA-DR with incidence of posttransplant hip fracture in kidney transplant recipients | Q46189621 | ||
| Impact of de novo donor-specific HLA antibodies detected by Luminex solid-phase assay after transplantation in a group of 88 consecutive living-donor renal transplantations | Q46897107 | ||
| Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: diagnostic considerations in the evaluation of liver allografts | Q46947691 | ||
| Human leukocyte antigen antibodies and chronic rejection: from association to causation | Q47563762 | ||
| Significance of the positive crossmatch test in kidney transplantation | Q47800073 | ||
| Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. | Q48005087 | ||
| Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads. | Q50618048 | ||
| Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. | Q50674616 | ||
| Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation. | Q50895880 | ||
| C4d fixing, luminex binding antibodies - a new tool for prediction of graft failure after heart transplantation. | Q50899566 | ||
| Desensitization in HLA-incompatible kidney recipients and survival. | Q51018759 | ||
| Luminex-based desensitization protocols: the University of Wisconsin initial experience. | Q51038073 | ||
| Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy. | Q51413561 | ||
| Detection of antibodies against HLA-C epitopes in patients with rejected kidney transplants. | Q51621019 | ||
| Eighteen-year follow-up of a retrospective study of HLA antibody on kidney graft survival. | Q51794444 | ||
| Predicting the immunogenicity of human leukocyte antigen class I alloantigens using structural epitope analysis determined by HLAMatchmaker. | Q51874425 | ||
| Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation. | Q51941761 | ||
| A non-allogeneic stimulus triggers the production of de novo HLA antibodies in healthy adults. | Q51969757 | ||
| HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. | Q52041500 | ||
| Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry. | Q52668051 | ||
| P433 | issue | 6 | |
| P921 | main subject | immunology | Q101929 |
| organ transplantation | Q69253852 | ||
| P304 | page(s) | 351-368 | |
| P577 | publication date | 2016-12-01 | |
| P1433 | published in | International Journal of Immunogenetics | Q15755115 |
| P1476 | title | Clinical and immunological relevance of antibodies in solid organ transplantation | |
| P478 | volume | 43 |
| Q55433988 | Does human leukocyte antigens sensitization matter for xenotransplantation? |
| Q39293464 | Herpesvirus microRNAs for use in gene therapy immune-evasion strategies |
| Q50193535 | Impact of human leukocyte antigen mismatch on lung transplant outcome |
| Q90537689 | Measuring alloreactive B cell responses in transplant recipients |
Search more.